Abstract
Gap junctions, assembled from connexins, form the cell-to-cell pathways for propagation of the precisely orchestrated patterns of current flow that govern the normal rhythm of the healthy heart. As in most tissues and organs, multiple connexin types are co-expressed in the heart; connexin43, connexin40 and connexin45 are found in distinctive combinations and relative quantities in different, functionally-specialized subsets of cardiomyocyte. Alterations of gap junction organization and connexin expression are now well established as a consistent feature of human heart disease in which there is an arrhythmic tendency. These alterations may take the form of structural remodeling, involving disturbances in the distribution of gap junctions, and/or remodeling of connexin expression, involving alteration of the amount or type of connexin(s) expressed. In the diseased ventricle, the most consistent quantitative alteration involves heterogeneous reduction in connexin43 expression. In the atria, features of gap junction organization and connexin expression may contribute to both the initiation and persistence of atrial fibrillation. By correlating data from studies on the human patient with those from animal and cell models, alterations in gap junctions and connexins have emerged as important factors to be considered in understanding the pro-arrhythmic substrate found in a variety of forms of heart disease. Our knowledge of the functional correlates of the specific patterns of connexin co-expression in different subsets of myocyte in the healthy and diseased heart still remains limited, however, and the development of new experimental cell models heralds future advances in this field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alcolea S, Theveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzouanacou E, Chauvin JP, Briand JP, Moorman AF, Lamers WH, Gros DB (1999) Downregulation of connexin 45 gene products during mouse heart development. Circ Res 84:1365–1379
Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230–246
Angst BD, Khan LUR, Severs NJ, Whitely K, Rothery S, Thompson RP, Magee AI, Gourdie RG (1997) Dissociated spatial patterning of gap junctions and cell adhesion junctions during postnatal differentiation of ventricular myocardium. Circ Res 80:88–94
Ausma J, van der Velden HM, Lenders MH, van Ankeren EP, Jongsma HJ, Ramaekers FC, Borgers M, Allessie MA (2003) Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107:2051–2058
Barker RJ, Price RL, Gourdie RG (2002) Increased association of ZO-1 with connexin43 during remodeling of cardiac gap junctions. Circ Res 90:317–324
Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O (1993) Gap junction protein connexin40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73:1138–1149
Beardslee MA, Lerner DL, Tadros PN, Laing JG, Beyer EC, Yamada KA, Kléber AG, Schuessler RB, Saffitz JE (2000) Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 87:656–662
Beyer E, Seul KH, Larson DM (1997) Cardiovascular gap junction proteins: molecular characterization and biochemical regulation. In: De Mello WC, Janse MJ, Norwell MA (eds) Heart Cell Communication in Health and Disease. Kluwer, New York, pp 45–51
Bukauskas FF, Elfgang C, Willecke K, Weingart R (1995) Biophysical properties of gap junction channels formed by mouse connexin40 in induced pairs of transfected human HeLa cells. Biophys J 68:2289–2298
Camici PG, Wijns W, Borgers M, DeSilva R, Ferrari R, Knuuti J, Lammertsma AA, Liedtke AJ, Paternostro G, Vatner SF (1997) Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 96:3205–3214
Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ (1998) HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95:2979–2984
Coppen SR, Dupont E, Rothery S, Severs NJ (1998) Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82:232–243
Coppen SR, Gourdie RG, Severs NJ (2001) Connexin45 is the first connexin to be expressed in the central conduction system of the mouse heart. Exp Clin Cardiol 6:17–23
Coppen SR, Kaba RA, Halliday D, Dupont E, Skepper JN, Elneil S, Severs NJ (2003) Comparison of connexin expression patterns in the developing mouse heart and human foetal heart. Mol Cell Biochem 242:121–127
Coppen SR, Kodama I, Boyett MR, Dobrzynski H, Takagishi Y, Honjo H, Yeh H-I, Severs NJ (1999a) Connexin45, a major connexin of the rabbit sinoatrial node, is co-expressed with connexin43 in a restricted zone at the nodal-crista terminalis border. J Histochem Cytochem 47:907–918
Coppen SR, Severs NJ (2002) Diversity of connexin expression patterns in the atrioventricular node: vestigial consequence or functional specialization? J Cardiovasc Electrophysiol 13:625–626
Coppen SR, Severs NJ, Gourdie RG (1999b) Connexin45 (a6) expression delineates an extended conduction system in theembryonic and mature rodent heart. Dev Genet 24:82–90
Daleau P, Boudriau S, Michaud M, Jolicoeur C, Kingma JG, Jr. (2001) Preconditioning in the absence or presence of sustained ischemia modulates myocardial Cx43 protein levels and gap junction distribution. Can J Physiol Pharmacol 79:371–378
Davis LM, Rodefeld ME, Green K, Beyer EC, Saffitz JE (1995) Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol 6:813–822
Dupont E, Ko YS, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ (2001a) The gap-junctional protein, connexin40, is elevated in patients susceptible to post-operative atrial fibrillation. Circulation 103:842–849
Dupont E, Matsushita T, Kaba R, Vozzi C, Coppen SR, Khan N, Kaprielian R, Yacoub MH, Severs NJ (2001b) Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol 33:359–371
Elvan A, Huang X, Pressler ML, Zipes DP (1997) Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin43 in dogs. Circulation 96:1675–1685
Emdad L, Uzzaman M, Takagishi Y, Honjo H, Uchida T, Severs NJ, Kodama I, Murata Y (2001) Gap junction remodelling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. J Mol Cell Cardiol 33:219–231
Gourdie RG, Green CR, Severs NJ (1991) Gap junction distribution in adult mammalian myocardium revealed by an antipeptide antibody and laser scanning confocal microscopy. J Cell Sci 99:41–55
Gourdie RG, Severs NJ, Green CR, Rothery S, Germroth P, Thompson RP (1993) The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of the cardiac atrioventricular conduction system. J Cell Sci 105:985–991
Green CR, Severs NJ (1993) Distribution and role of gap junctions in normal myocardium and human ischemic heart disease. Histochemistry 99:105–120
Gros D, Jarry-Guichard T, ten Velde I, De Mazière AMGL, Van Kempen MJA, Davoust J, Briand JP, Moorman AFM, Jongsma HJ (1994) Restricted distribution of connexin40, a gap junctional protein, in mammalian heart. Circ Res 74:839–851
Guerrero PA, Schuessler RB, Davis LM, Beyer EC, Johnson CM, Yamada KA, Saffitz JE (1997) Slow ventricular conduction in mice heterozygous for connexin43 null mutation. J Clin Invest 99:1991–1998
Gutstein DE, Liu FY, Zhang J, Chen FL, Ghodsi N, Kini AS, Fishman GI (2002) Progressive loss of connexin43 in the heart yields a phenotypic shift from ventricular dysfunction to fatal arrhythmias. Circulation 106:767
Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, Chien KR, Stuhlmann H, Fishman GI (2001a) Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88:333–339
Gutstein DE, Morley GE, Vaidya D, Liu F, Chen FL, Stuhlmann H, Fishman GI (2001b) Heterogeneous expression of gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation 104:1194–1199
Hall DG, Morley GE, Vaidya D, Ard M, Kimball TR, Witt SA, Colbert MC (2000) Early onset heart failure in transgenic mice with dilated cardiomyopathy. Pediatr Res 48:36–42
Heusch G (1998) Hibernating myocardium. Physiol Rev 78:1055–1085
Honjo H, Boyett MR, Coppen SR, Takagishi Y, Severs NJ, Kodama I (2002) Heterogeneous expression of connexins in rabbit sinoatrial node cells: correlation between connexin isoform and cell size. Cardiovasc Res 50:89–96
Hoyt RH, Cohen ML, Saffitz JE (1989) Distribution and three-dimensional structure of intercellular junctions in canine myocardium. Circ Res 64:563–574
Jain SK, Schuessler RB, Saffitz JE (2003) Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res 92:1138–1144
Jalife J (2003) Rotors and spiral waves in atrial fibrillation. J Cardiovasc Electrophysiol 14:776–780
Jongsma HJ, Wilders R (2000) Gap junctions in cardiovascular disease. Circ Res 86:1193–1197
Kaba RA, Coppen SR, Dupont E, Skepper JN, Elneil S, Haw MP, Pepper JR, Yacoub MH, Rothery S, Severs NJ (2001) Comparison of connexin 43, 40 and 45 expression patterns in the developing human and mouse hearts. Cell Communication and Adhesion 8:339–343
Kaba RA, Coppen SR, Rothery S, Dupont E, Yacoub MH, De Souza AC, Pepper JR, Severs N (2003) Relevance of cardiac gap junctions to the clinical course of patients with chronic atrial fibrillation. Eur Heart J 24:508
Kanagaratnam P, Cherian A, Stanbridge RD, Glenville B, Severs NJ, Peters NS (2004) Relationship between connexins and atrial activation during human atrial fibrillation. J Cardiovasc Electrophysiol 15:206–216
Kanno S, Kovacs A, Yamada KA, Saffitz JE (2003)Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 41:681–686
Kanno S, Saffitz JE (2001) The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 10:169–177
Kaprielian RR, Gunning M, Dupont E, Sheppard MN, Rothery SM, Underwood R, Pennell DJ, Fox K, Pepper J, Poole-Wilson PA, Severs NJ (1998) Down-regulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation 97:651–660
Kitamura H, Ohnishi Y, Yoshida A, Okajima K, Azumi H, Ishida A, Galeano EJ, Kubo S, Hayashi Y, Itoh H, Yokoyama M (2002) Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J Cardiovasc Electrophysiol 13:865–870
Ko YS, Yeh HI, Ko YL, Hsu YC, Chen CF, Wu S, Lee YS, Severs NJ (2004) Three-dimensional reconstruction of the rabbit atrioventricular conduction axis by combining histological, desmin, and connexin mapping data. Circulation 109:1172–1179
Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J (2004) Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 62:426–436
Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54:361–379
Kostin S, Rieger M, Dammer S, Hein S, Richter M, Klovekorn WP, Bauer EP, Schaper J (2003) Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem 242:135–144
Lerner DL, Beardslee MA, Saffitz JE (2001) The role of altered intercellular coupling in arrhythmias induced by acute myocardial ischemia. Cardiovasc Res 50:263–269
Lerner DL, Yamada KA, Schuessler RB, Saffitz JE (2000) Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101:547–552
Luke RA, Saffitz JE (1991) Remodeling of ventricular conduction pathways in healed canine infarct border zones. J Clin Invest 87:1594–1602
Martinez AD, Hayrapetyan V, Moreno AP, Beyer EC (2002) Connexin43 and connexin45 form heteromeric gap junction channels in which individual components determine permeability and regulation. Circ Res 90:1100–1107
Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, Wada Y, Oka T, Takamatsu T (1999) Remodeling of cell-cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ Res 85:1046–1055
Moreno AP, Laing JG, Beyer EC, Spray DC (1995) Properties of gap junction channels formed of connexin 45 endogenously expressed in human hepatoma (SKHep1) cells. Am J Physiol 268:C356–C365
Morley GE, Vaidya D, Samie FH, Lo C, Delmar M, Jalife J (1999) Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10:1361–1375
Nao T, Ohkusa T, Hisamatsu Y, Inoue N, Matsumoto T, Yamada J, Shimizu A, Yoshiga Y, Yamagata T, Kobayashi S, Yano M, Hamano K, Matsuzaki M (2003) Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm. Am J Cardiol 91:678–683
Peters NS, Green CR, Poole-Wilson PA, Severs NJ (1993) Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischaemic human hearts. Circulation 88:864–875
Peters NS, Severs NJ, Coromilas J, Wit AL (1997) Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95:988–996
Peters NS, Severs NJ, Rothery SM, Lincoln C, Yacoub MH, Green CR (1994) Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 90:713–725
Petrich BG, Eloff BC, Lerner DL, Kovacs A, Saffitz JE, Rosenbaum DS, Wang Y (2004) Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. J Biol Chem 279:15330–15338
Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, Wang Y (2002) c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 91:640–647
Pimentel RC, Yamada KA, Kléber AG, Saffitz JE (2002) Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res 90:671–677
Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim J-S, Lamers WH, Evert M, Meda P, Traub O, Willecke K (2000) Unique and shared functions of different connexins in mice. Curr Biol 10:1083–1091
Polontchouk L, Haefliger J-A, Ebelt B, Schafer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, Rainer De Vivie E, Dhein S (2001) Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38:883–891
Rohr S, Kucera JP, Fast VG, Kléber AG (1997) Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science 275:841–844
Rudy Y, Shaw RM (1997) Cardiac excitation: an interactive process of ion channels and gap junctions. Adv Exp Med Biol 430:269–279
Saffitz JE, Kléber AG (2004) Effects of mechanical forces and mediators of hypertrophy on remodeling of gap junctions in the heart. Circ Res 94:585–591
Sakabe M, Fujiki A, Nishida K, Sugao M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H (2004) Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Pharmacol 43:851–859
Schulz R, Gres P, Skyschally A, Duschin A, Belosjorow S, Konietzka I, Heusch G (2003) Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo. FASEB J 17:1355–1357
Schulz R, Heusch G (2004) Connexin 43 and ischemic preconditioning. Cardiovasc Res 62:335–344
Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, Heusch G (2002) No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol (Heart Circ Physiol) 283:H1740–H1742
Sepp R, Severs NJ, Gourdie RG (1996) Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy. Heart 76:412–417
Severs NJ (1985) Intercellular junctions and the cardiac intercalated disk. In: Harris P, Poole-Wilson PA (eds) Advances in myocardiology. Plenum, New York, pp 223–242
Severs NJ (1989) Constituent cells of the heart and isolated cell models in cardiovascular research. In: Piper HM, Isenberg G (Eds) Isolated adult cardiomyocytes. volume 1. CRC, Boca Raton, pp 3–41
Severs NJ (1999) Cardiovascular disease. In: Cardew G (Ed.) Gap junction-mediated intercellular signalling in health and disease. Wiley, New York, pp 188–206
Severs NJ (2001) Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence? J Cell Mol Med 5:355–366
Severs NJ (2002) Gap junctions and connexin expression in human heart disease. In: De Mello WC, Janse MJ (eds) Heart cell coupling and impulse propagation in health and disease. Kluwer, Boston, pp 321–334
Severs NJ (2003) Communicating junctions, connexins and the cardiomyocyte: from cell biology to cardiology. In: Singal PK, Dixon IMC, Kirshenbaum LA, Dhalla NS (Eds) Cardiac remodeling and failure. Kluwer, Boston, pp 417–434
Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T (2004a) Gap junction alterations in human cardiac disease. Cardiovasc Res 62:368–377
Severs NJ, Dupont E, Coppen SR, Halliday D, Inett E, Baylis D, Rothery S (2004b) Remodelling of gap junctions and connexin expression in heart disease. Biochim Biophys Acta 1662:138–148
Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh H-I, Ko Y-S, Matsushita T, Kaba R, Halliday D (2001) Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech 52:301–322
Shaw RM, Rudy Y (1997) Ionic mechanisms of propagation in cardiac tissue — roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 81:727–741
Smith JH, Green CR, Peters NS, Rothery S, Severs NJ (1991) Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol 139:801–821
Spach MS, Heidlage JF, Dolber PC, Barr RC (2000) Electrophysiological effects of remodeling cardiac gap junctions and cell size. Circ Res 86:302–311
Spach MS, Starmer CF (1995) Altering the topology of gap junctions, a major therapeutic target for atrial fibrillation. Cardiovasc Res 30:337–344
Uzzaman M, Honjo H, Takagishi Y, Emdad L, Magee AI, Severs NJ, Kodama I (2000) Remodeling of gap-junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension. Circ Res 86:871–878
van der Velden HM, Jongsma HJ (2002a) Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. Cardiovasc Res 54:270–279
van der Velden HM, van Kempen MJ, Wijffels MC, van Zijverden M, Groenewegen WA, Allessie MA, Jongsma HJ (1998) Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol 9:596–607
van der Velden HMW, Ausma J, Rook MB, Hellemons AJCGM, Van Veen TAAB, Allessie MA, Jongsma HJ (2000) Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res 46:476–486
van der Velden HMW, Jongsma HJ (2002b) Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. Cardiovasc Res 54:270–279
Van Kempen MJA, ten Velde I, Wessels A, Oosthoek PW, Gros D, Jongsma HJ, Moorman AFM, Lamers WH (1995) Differential connexin distribution accommodates cardiac function in different species. Microsc Res Tech 31:420–436
Van Kempen MJA, Vermeulen JLM, Moorman AFM, Gros D, Paul DL, Lamers WH (1996) Developmental changes of connexin40 and connexin43 messenger RNA. Cardiovasc Res 32:886–900
van Veen TA, van Rijen HV, Jongsma HJ (2000) Electrical conductance of mouse connexin45 gap junction channels is modulated by phosphorylation. Cardiovasc Res 46:496–510
Veenstra RD, Wang HZ, Beyer EC, Brink PR (1994) Selective dye and ionic permeability of gap junction channels formed by connexin45. Circ Res 75:483–490
Viswanathan PC, Shaw RM, Rudy Y (1999) Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 99:2466–2474
Vozzi C, Dupont E, Coppen SR, Yeh H-I, Severs NJ (1999) Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 31:991–1003
Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954–1968
Yamada KA, Rogers JG, Sundset R, Steinberg TH, Saffitz JE (2003) Up-regulation of connexin45 in heart failure. J Cardiovasc Electrophysiol 14:1205–1212
Yao JA, Gutstein DE, Liu FY, Wit AL, Fishman GI (2002) Dissociation of heart function from electrophysiological properties of gap junctions in cardiac-restricted connexin43 knockout mice. Circulation 106:638
Yeh H-I, Lai Y-J, Lee S-H, Lee Y-N, Ko Y-S, Chen S-A, Severs NJ, Tsai C-H (2001) Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation 104:3152–3157
Yeh HI, Hou SH, Hu HR, Lee YN, Li JY, Dupont E, Coppen SR, Ko YS, Severs NJ, Tsai CH (2002) Alteration of gap junctions and connexins in the right atrial appendage during cardiopulmonary bypass. J Thorac Cardiovasc Surg 124:1106–1112
Zipes DP (1997) Specific arrhythmias: diagnosis and treatment. In: Braunwald E (ed) Heart disease. WB Saunders, Philadelphia, pp 640–704
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Severs, N.J., Dupont, E., Kaba, R., Thomas, N. (2005). Gap Junction and Connexin Remodeling in Human Heart Disease. In: Winterhager, E. (eds) Gap Junctions in Development and Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28621-7_4
Download citation
DOI: https://doi.org/10.1007/3-540-28621-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-26156-8
Online ISBN: 978-3-540-28621-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)